6.
Abdelhaleem H, Gamal Eldeen H, Nabeel M, Abdelmoniem R, Elakel W, Zayed N
. Evaluation of acoustic radiation force impulse (ARFI) elastography as non-invasive diagnostic tool in living donor liver transplantation. Abdom Radiol (NY). 2018; 44(2):464-472.
DOI: 10.1007/s00261-018-1732-8.
View
7.
Sebagh M, Samuel D, Maria Antonini T, Coilly A, Esposti D, Roche B
. Twenty-year protocol liver biopsies: Invasive but useful for the management of liver recipients. J Hepatol. 2011; 56(4):840-7.
DOI: 10.1016/j.jhep.2011.11.016.
View
8.
Venturi C, Sempoux C, Bueno J, Ferreres Pinas J, Bourdeaux C, Abarca-Quinones J
. Novel histologic scoring system for long-term allograft fibrosis after liver transplantation in children. Am J Transplant. 2012; 12(11):2986-96.
DOI: 10.1111/j.1600-6143.2012.04210.x.
View
9.
Azhie A, Sharma D, Sheth P, Qazi-Arisar F, Zaya R, Naghibzadeh M
. A deep learning framework for personalised dynamic diagnosis of graft fibrosis after liver transplantation: a retrospective, single Canadian centre, longitudinal study. Lancet Digit Health. 2023; 5(7):e458-e466.
DOI: 10.1016/S2589-7500(23)00068-7.
View
10.
Deurdulian C, Grant E, Tchelepi H, Latterman P, Paluch J, Chopra S
. Assessment of Fibrosis in Liver Transplant Recipients: Diagnostic Performance of Shear Wave Elastography (SWE) and Correlation of SWE Findings With Biopsy Results. AJR Am J Roentgenol. 2019; 213(6):W264-W271.
DOI: 10.2214/AJR.19.21160.
View
11.
Perito E, Persyn E, Bucuvalas J, Martinez M, Mohammad S, Squires J
. Graft Fibrosis Over 10 to 15 Years in Pediatric Liver Transplant Recipients: Multicenter Study of Paired, Longitudinal Surveillance Biopsies. Liver Transpl. 2022; 28(6):1051-1062.
DOI: 10.1002/lt.26409.
View
12.
Kimura Y, Taura K, Nam N, Uemoto Y, Yoshino K, Ikeno Y
. Utility of Mac-2 Binding Protein Glycosylation Isomer to Evaluate Graft Status After Liver Transplantation. Liver Transpl. 2020; 27(3):403-415.
DOI: 10.1002/lt.25870.
View
13.
Korda D, Lenard Z, Gerlei Z, Jakab Z, Haboub-Sandil A, Wagner L
. Shear-wave elastography for the assessment of liver fibrosis in liver transplant recipients treated for hepatitis C virus recurrence. Eur J Gastroenterol Hepatol. 2017; 30(1):27-32.
DOI: 10.1097/MEG.0000000000001003.
View
14.
Demetris A, Adeyi O, Bellamy C, Clouston A, Charlotte F, Czaja A
. Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology. 2006; 44(2):489-501.
DOI: 10.1002/hep.21280.
View
15.
Imai H, Kamei H, Onishi Y, Ishizu Y, Ishigami M, Goto H
. Diagnostic Usefulness of APRI and FIB-4 for the Prediction of Liver Fibrosis After Liver Transplantation in Patients Infected with Hepatitis C Virus. Transplant Proc. 2018; 50(5):1431-1436.
DOI: 10.1016/j.transproceed.2018.03.005.
View
16.
Diamond D, Krasnoselsky A, Burnum K, Monroe M, Webb-Robertson B, McDermott J
. Proteome and computational analyses reveal new insights into the mechanisms of hepatitis C virus-mediated liver disease posttransplantation. Hepatology. 2012; 56(1):28-38.
PMC: 3387320.
DOI: 10.1002/hep.25649.
View
17.
Montano-Loza A, Bhanji R, Wasilenko S, Mason A
. Systematic review: recurrent autoimmune liver diseases after liver transplantation. Aliment Pharmacol Ther. 2016; 45(4):485-500.
DOI: 10.1111/apt.13894.
View
18.
Gonzalez I, Hartley C, Nalbantoglu I
. Recurrent Autoimmune Hepatitis and De Novo Autoimmune Hepatitis in the Liver Allograft. Am J Clin Pathol. 2020; 155(3):435-445.
DOI: 10.1093/ajcp/aqaa147.
View
19.
Dubois M, Ronot M, Houssel-Debry P, Brun V, Rayar M, Auger M
. Performance of B-mode ratio and 2D shear wave elastography for the detection and quantification of hepatic steatosis and fibrosis after liver transplantation. Eur J Gastroenterol Hepatol. 2019; 32(2):222-230.
DOI: 10.1097/MEG.0000000000001500.
View
20.
Mahrouf-Yorgov M, Collin de lHortet A, Cosson C, Slama A, Abdoun E, Guidotti J
. Increased susceptibility to liver fibrosis with age is correlated with an altered inflammatory response. Rejuvenation Res. 2011; 14(4):353-63.
DOI: 10.1089/rej.2010.1146.
View